IGC Pharma
IGC • AMEX
IGC Pharma is a conglomerates company in the industrials sector trading on AMEX, led by CEO Ram Mukunda, with a market cap of $25.2M.
CEORam Mukunda
Next Earnings
No upcoming earnings scheduled for IGC Pharma
No earnings announcement scheduled
Earnings History
Past 12 earnings reports for IGC Pharma
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 19, 2026 | Q3 2026 | -$0.01Est: -$0.02 | +50.0% | $213.0KEst: $392.1K | -45.7% | — |
| Nov 17, 2025 | Q2 2026 | -$0.02Est: -$0.02 | 0.0% | $191.0KEst: $353.8K | -46.0% |  10-Q |
| Aug 14, 2025 | Q1 2026 | -$0.02Est: -$0.03 | +33.3% | $328.0KEst: $327.6K | +0.1% | 10-Q |
| Jun 27, 2025 | Q4 2025 | -$0.01Est: -$0.02 | +50.0% | $330.0KEst: $305.0K | +8.2% | 10-K |
| Feb 18, 2025 | Q3 2025 | -$0.02Est: -$0.03 | +33.3% | $257.0KEst: $204.0K | +26.0% | 10-Q |
| Nov 12, 2024 | Q2 2025 | -$0.02Est: -$0.03 | +33.3% | $412.0KEst: $300.0K | +37.3% | 10-Q |
| Aug 8, 2024 | Q1 2025 | -$0.03Est: -$0.04 | +25.0% | $272.0KEst: $620.0K | -56.1% | 10-Q |
| Jun 24, 2024 | Q4 2024 | -$0.04Est: -$0.04 | 0.0% | $295.0KEst: $190.0K | +55.3% | 10-K |
| Feb 14, 2024 | Q3 2024 | -$0.09 | — | $204.0K | — | 10-Q |
| Nov 13, 2023 | Q2 2024 | -$0.05 | — | $291.0K | — | — |
| Aug 10, 2023 | Q1 2024 | -$0.04 | — | $555.0K | — | 10-Q |
| Jul 7, 2023 | Q4 2023 | -$0.08 | — | $166.0K | — | 10-K |